Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis

A. Petrackova, P. Horak, M. Radvansky, R. Fillerova, V. Smotkova Kraiczova, M. Kudelka, F. Mrazek, M. Skacelova, A. Smrzova, E. Kriegova,

. 2020 ; 38 (2) : 289-298. [pub] 20190803

Language English Country Italy

Document type Journal Article

OBJECTIVES: A growing body of evidence highlights the persistent activation of the innate immune system and type I interferon (IFN) signature in the pathogenesis of rheumatoid arthritis (RA) and its association with disease activity. Since the recent study revealed heterogeneity in the IFN signature in RA, we investigated for the first time the heterogeneity in innate signature in RA. METHODS: The innate gene expression signature (10 TLRs, 7 IL1/IL1R family members, and CXCL8/IL8) was assessed in peripheral blood mononuclear cells from RA patients (n=67), both with active (DAS28≥3.2, n=32) and inactive disease (DAS28<3.2, n=35), and in healthy control subjects (n=55). RESULTS: Of the 13 deregulated innate genes (TLR2, TLR3, TLR4, TLR5, TLR8, TLR10, IL1B, IL1RN, IL18, IL18R1, IL1RAP, and SIGIRR/IL1R8) associated with RA, TLR10 and IL1RAP are being reported for the first time. Multivariate analysis based on utilising patient similarity networks revealed the existence of four patient's subsets (clusters) based on different TLR8 and IL1RN expression profiles, two in active and two in inactive RA. Moreover, neural network analysis identified two main gene sets describing active RA within an activity-related innate signature (TLR1, TLR2, TLR3, TLR7, TLR8, CXCL8/IL8, IL1RN, IL18R1). When comparing active and inactive RA, upregulated TLR2, TLR4, TLR6, and TLR8 and downregulated TLR10 (P<0.04) expression was associated with the disease activity. CONCLUSIONS: Our study on the comprehensive innate gene profiling together with multivariate analysis revealed a certain heterogeneity in innate signature within RA patients. Whether the heterogeneity of RA elucidated from diversity in innate signatures may impact the disease course and treatment response deserves future investigations.

000      
00000naa a2200000 a 4500
001      
bmc20023128
003      
CZ-PrNML
005      
20201214125330.0
007      
ta
008      
201125s2020 it f 000 0|eng||
009      
AR
035    __
$a (PubMed)31376255
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Petrackova, Anna $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
245    10
$a Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis / $c A. Petrackova, P. Horak, M. Radvansky, R. Fillerova, V. Smotkova Kraiczova, M. Kudelka, F. Mrazek, M. Skacelova, A. Smrzova, E. Kriegova,
520    9_
$a OBJECTIVES: A growing body of evidence highlights the persistent activation of the innate immune system and type I interferon (IFN) signature in the pathogenesis of rheumatoid arthritis (RA) and its association with disease activity. Since the recent study revealed heterogeneity in the IFN signature in RA, we investigated for the first time the heterogeneity in innate signature in RA. METHODS: The innate gene expression signature (10 TLRs, 7 IL1/IL1R family members, and CXCL8/IL8) was assessed in peripheral blood mononuclear cells from RA patients (n=67), both with active (DAS28≥3.2, n=32) and inactive disease (DAS28<3.2, n=35), and in healthy control subjects (n=55). RESULTS: Of the 13 deregulated innate genes (TLR2, TLR3, TLR4, TLR5, TLR8, TLR10, IL1B, IL1RN, IL18, IL18R1, IL1RAP, and SIGIRR/IL1R8) associated with RA, TLR10 and IL1RAP are being reported for the first time. Multivariate analysis based on utilising patient similarity networks revealed the existence of four patient's subsets (clusters) based on different TLR8 and IL1RN expression profiles, two in active and two in inactive RA. Moreover, neural network analysis identified two main gene sets describing active RA within an activity-related innate signature (TLR1, TLR2, TLR3, TLR7, TLR8, CXCL8/IL8, IL1RN, IL18R1). When comparing active and inactive RA, upregulated TLR2, TLR4, TLR6, and TLR8 and downregulated TLR10 (P<0.04) expression was associated with the disease activity. CONCLUSIONS: Our study on the comprehensive innate gene profiling together with multivariate analysis revealed a certain heterogeneity in innate signature within RA patients. Whether the heterogeneity of RA elucidated from diversity in innate signatures may impact the disease course and treatment response deserves future investigations.
650    12
$a revmatoidní artritida $x genetika $x imunologie $x metabolismus $7 D001172
650    _2
$a lidé $7 D006801
650    12
$a interferon typ I $x imunologie $7 D007370
650    _2
$a leukocyty mononukleární $7 D007963
650    _2
$a multivariační analýza $7 D015999
650    12
$a toll-like receptory $x genetika $x imunologie $x metabolismus $7 D051193
650    _2
$a transkriptom $7 D059467
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horak, Pavel $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
700    1_
$a Radvansky, Martin $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Czech Republic.
700    1_
$a Fillerova, Regina $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
700    1_
$a Smotkova Kraiczova, Veronika $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
700    1_
$a Kudelka, Milos $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Czech Republic.
700    1_
$a Mrazek, Frantisek $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
700    1_
$a Skacelova, Martina $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
700    1_
$a Smrzova, Andrea $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
700    1_
$a Kriegova, Eva $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic. eva.kriegova@email.cz.
773    0_
$w MED00001116 $t Clinical and experimental rheumatology $x 0392-856X $g Roč. 38, č. 2 (2020), s. 289-298
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31376255 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125330 $b ABA008
999    __
$a ok $b bmc $g 1595447 $s 1113804
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 38 $c 2 $d 289-298 $e 20190803 $i 0392-856X $m Clinical and Experimental Rheumatology $n Clin Exp Rheumatol $x MED00001116
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...